IndraLab
Statements
sparser
"To determine whether USP13 contributes to malignant phenotypes, we established HCT116 and HCT15 cell lines stably overexpressing wild-type USP13 (USP13-WT) or its catalytically inactive mutant USP13-AE (C345A/M664/739E) (Fig. xref a), and generated USP13-knockout RKO and SW48 cells via CRISPR/Cas9 (Fig. xref b)."